Industry Alliances

AskBio has collaborated with several pharmaceutical and medical device companies to advance gene therapies into the clinic including Medtronic, Baxter and Pfizer. AskBio has built and maintained an expansive portfolios of curative gene therapy technology that has been the basis of several AskBio portfolio companies including Actus Therapeutics (developing gene therapies for Pompe disease), NanoCor Therapeutics (partnered with Medtronic to develop treatments for heart failure), Chatham Therapeutics (sold to Baxter to develop hemophilia treatments) and Bamboo Therapeutics (sold to Pfizer to develop cures for rare neuromuscular diseases and muscular dystrophy).